quickly get a reliabe diagnosis

Innovation for laboratories



reliable diagnosis

Questions regarding GynTect?

Get the answers!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.


If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.


Vertriebspartnerschaft zwischen der oncgnostics GmbH und der EUROIMMUN Medizinische Labordiagnostika AGoncgnostics GmbH Susann Nuernberger / EUROIMMUN Medizinische Labordiagnostika AG

International sales partnership with EUROIMMUN for Distribution of GynTect

Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a PerkinElmer company. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect,…
Anwendung der PCR-Methode im oncgnostics-Labor

PCR: Certainty in the shortest possible time

The method of the PCR stands for the polymerase chain reaction. The underlying process has fundamentally changed medical and biotechnological research. It is now considered the most important laboratory method for investigating the molecular…
Theresa Erler im Labor der oncgnostics GmbHEberhard Schorr / oncgnostics GmbH

Looking back on a successful year of research

2020 was a challenging year - also for our company. Nevertheless, we look back on successful achievements. GynTect® convinces in test comparison In November, the journal Clinical Epigenetics published a comparative study on cervical cancer…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.